Determinants of saxagliptin use among patients with type 2 diabetes mellitus treated with oral anti-diabetic drugs

BACKGROUND: The patterns and determinants of saxagliptin use among patients with type 2 diabetes mellitus (T2DM) are unknown in real-world settings. We compared the characteristics of T2DM patients who were new initiators of saxagliptin to those who were new initiators of non-dipeptidyl peptidase-4...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pharmacol Toxicol
Main Authors: Saine, M Elle, Carbonari, Dena M, Newcomb, Craig W, Nezamzadeh, Melissa S, Haynes, Kevin, Roy, Jason A, Cardillo, Serena, Hennessy, Sean, Holick, Crystal N, Esposito, Daina B, Gallagher, Arlene M, Bhullar, Harshvinder, Strom, Brian L, Re, Vincent Lo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4404079/
https://ncbi.nlm.nih.gov/pubmed/25889498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-015-0007-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados